"
Team:Potsdam Bioware
From 2012.igem.org
| Line 1: | Line 1: | ||
| - | |||
<div class="box_round"> | <div class="box_round"> | ||
| - | {| | + | {| |
!align="center"|[[Team:Potsdam_Bioware|Home]] | !align="center"|[[Team:Potsdam_Bioware|Home]] | ||
!align="center"|[[Team:Potsdam_Bioware/Team|Team]] | !align="center"|[[Team:Potsdam_Bioware/Team|Team]] | ||
| Line 13: | Line 12: | ||
|} | |} | ||
</div> | </div> | ||
| + | |||
| + | |||
| + | |||
==Direct Antibody Identification, Maturation and Production in CHO-Cells== | ==Direct Antibody Identification, Maturation and Production in CHO-Cells== | ||
| Line 97: | Line 99: | ||
.box_round { | .box_round { | ||
padding: 5px; | padding: 5px; | ||
| - | border-radius: | + | border-radius: 5px; |
background: #cb9840; | background: #cb9840; | ||
background: -moz-linear-gradient(top, #cb9840 0%, #a77b34 100%); | background: -moz-linear-gradient(top, #cb9840 0%, #a77b34 100%); | ||
| Line 107: | Line 109: | ||
filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#cb9840', endColorstr='#a77b34',GradientType=0 ); | filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#cb9840', endColorstr='#a77b34',GradientType=0 ); | ||
box-shadow:8px 8px 8px #666; | box-shadow:8px 8px 8px #666; | ||
| + | } | ||
| + | |||
| + | .box_round table { | ||
| + | background-color: transparent; | ||
| + | } | ||
| + | |||
| + | table th { | ||
| + | padding-left: 5px; | ||
| + | padding-right: 5px; | ||
} | } | ||
Revision as of 21:19, 24 August 2012
| Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
|---|
Direct Antibody Identification, Maturation and Production in CHO-Cells
Project Description
Antibodies are versatile molecules for research and therapy and they are currently revolutionizing the market of biopharmaceuticals. To date, antibodies are generated in a laborious and time consuming manner. Either animal immunization followed by hybridoma technology or phage display is used to identify desired genes, which then need to be transferred to a production cell line such as CHO. We designed a streamlined workflow that incorporates all steps of antibody generation in CHO cells. Our plan is to stably transfect an antibody-fragment library in CHO cells. Antibody maturation is mimicked by further diversifying this library using the enzyme Activation-Induced cytidine Deaminase (AID), which is known to induce somatic hypermutation. Next, we plan to test and deploy a versatile and continuous viral selection system for clones producing the desired antibodies. Finally, we will try to employ a genetic switch to go from surface expression to soluble production of antibodies.
| Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
|---|
